beta-Endorphin in obstetric analgesia.

Area of Science:

• Obstetrics and Gynecology
• Pain Management
• Neuroscience

Background:

• Traditional analgesics used in labor can cross the blood-brain barrier, potentially affecting both mother and fetus.
• There is a need for effective and safe labor analgesia that minimizes central nervous system depression.

Purpose of the Study:

• To evaluate the efficacy and safety of intrathecal synthetic human beta-endorphin for labor analgesia.
• To assess the impact of beta-endorphin on maternal and fetal well-being during delivery.

Main Methods:

• 14 obstetric patients received intrathecal synthetic human beta-endorphin during labor.
• Maternal vital signs, consciousness, cooperation, and uterine contractions were monitored.
• Infant well-being was assessed using Apgar scores.

Main Results:

• All patients experienced rapid and prolonged analgesia.
• Uterine contractions remained normal, and all women were fully conscious and cooperative.
• No adverse effects on maternal respiration, cardiovascular, or central nervous systems were observed.
• Infants showed excellent Apgar scores.

Conclusions:

• Intrathecal synthetic human beta-endorphin is a safe and effective labor analgesic.
• Its inability to cross the blood-brain barrier prevents maternal and fetal central nervous system depression.
• Beta-endorphin represents a promising alternative to conventional labor analgesics.